Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase 1A/1B Clinical Trial of Drug Candidate LTI-01 October 27, 2015 Read More
Orphan Drug Status Granted to Lung Therapeutics Drug by The European Commission January 26, 2015 Read More
Lung Therapeutics, Inc. Receives FDA Orphan Drug Designation for Lead Drug Candidate LTI-01 December 2, 2014 Read More
Lung Therapeutics, Inc. Funded to Address Unmet Needs in Lung Injury and Disease October 29, 2014 Read More
Pharma Start-up Lung Therapeutics, Inc. Achieves Significant Funding to Address Unmet Needs in Lung Injury and Disease October 28, 2014 Read More
Pharma Start-Up Lung Therapeutics, Inc. Achieves Significant Funding to Address Unmet Needs in Lung Injury and Disease October 28, 2014 Read More
